Cellular senescence — the irreversible arrest of cell division — is now recognized as a primary driver of age-related tissue dysfunction. Senolytic compounds, which selectively eliminate these accumulated senescent cells, represent one of the most rapidly advancing areas of geroscience. This review examines the current evidence base and translational progress.
The Senescence Burden
Senescent cells accumulate with age, comprising 2-5% of total tissue cellularity in elderly individuals. While initially beneficial — serving as tumor suppressors and wound healing coordinators — their persistent accumulation drives chronic inflammation through the senescence-associated secretory phenotype (SASP). This pro-inflammatory secretome includes IL-6, IL-8, MCP-1, and matrix metalloproteinases that degrade tissue architecture and impair neighboring cell function.
Pioneering work at Mayo Clinic demonstrated that transplanting even a small number of senescent cells into young mice was sufficient to induce physical dysfunction, spread cellular senescence to host tissues, and reduce survival. Conversely, clearance of senescent cells in aged mice extended median lifespan by 25-35% and delayed the onset of age-associated pathology across multiple organ systems.
Clinical Translation
The first-in-human senolytic trial, published in EBioMedicine (2019), evaluated dasatinib plus quercetin (D+Q) in patients with idiopathic pulmonary fibrosis. The intermittent dosing protocol — three consecutive days per week over three weeks — produced measurable improvements in physical function, including 6-minute walk distance and timed chair stands, with acceptable tolerability.
Subsequent trials have expanded to diabetic kidney disease, Alzheimer-related cognitive decline, and osteoarthritis. While these studies remain in early phases, the consistent signal across diverse pathologies supports the hypothesis that senescent cell clearance addresses a root cause of aging rather than individual disease manifestations.
This article is intended for educational and informational purposes only. It does not constitute medical advice. All compounds discussed are intended for research purposes only.